Clinical Trials Directory

Trials / Completed

CompletedNCT03956264

Interest of Virtual Reality in the Management of Anxiety and Pain Related to Post-cardiac Surgery Care

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
200 (actual)
Sponsor
CMC Ambroise Paré · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study compares Virtual Reality versus Nitrous oxide administration for the management of anxiety and pain related to post-cardiac surgery care, especially during removal of mediastinal drainage.

Detailed description

After cardiac surgery, the mediastinal and pleural drains are usually removed the second postoperative day, in the absence of complications. This procedure, realized by nurses, is a source of anxiety and pain for patients. Nitrous oxide (Kalinox®) is commonly used to manage many situations of anxiety, including the removal of mediastinal and/or pleural drains, and has shown a greater effect than placebo in this indication. Virtual Reality (VR) is a recent technology that allows the representation of a pleasant environment in three dimensions with a complete immersion by a helmet. By distracting patients, this technology can reduce anxiety, discomfort and ultimately pain associated with care. This randomized monocentric trial compares VR versus Kalinox® administration for the management of anxiety and pain related to post-cardiac surgery care, especially mediastinal and/or pleural drain removal.

Conditions

Interventions

TypeNameDescription
DEVICEVirtual RealityDeepsen offers a VR platform that provides patients with immersive contents aimed to distract, inform, soften and improve the healthcare experience
DRUGKalinoxGas mixture composed of 50% Nitrous Oxide and 50% Oxygen

Timeline

Start date
2019-09-26
Primary completion
2020-07-24
Completion
2020-07-24
First posted
2019-05-20
Last updated
2026-04-08

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03956264. Inclusion in this directory is not an endorsement.